Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Adhikary, D. Articles by Mautner, J. Search for Related Content PubMed PubMed Citation Articles by Adhikary, D. Articles by Mautner, J. Related Collections Related Article Social Bookmarking                      What's this?

¹ Clinical Cooperation Group, Institute for Clinical and Molecular Biology, GSF-National Research Center for Environment and Health and ² Children's Hospital, Hematology-Oncology, Technical University Munich, 80804 Munich, Germany
³ Clinical Cooperation Group Molecular Oncology, Department of Gene Vectors, GSF-National Research Center for Environment and Health, ⁴ Department of Otorhinolaryngology, and ⁵ Laboratory of Immunogenetics, Ludwig Maximilians University, 81377 Munich, Germany

CORRESPONDENCE Josef Mautner: mautner{at}gsf.de

Epstein-Barr virus (EBV) establishes lifelong persistent infections in humans by latently infecting B cells, with occasional cycles of reactivation, virus production, and reinfection. Protective immunity against EBV is mediated by T cells, but the role of EBV-specific T helper (Th) cells is still poorly defined. Here, we study the Th response to the EBV lytic cycle proteins BLLF1 (gp350/220), BALF4 (gp110), and BZLF1 and show that glycoprotein-specific Th cells recognize EBV-positive cells directly; surprisingly, a much higher percentage of target cells than those expressing lytic cycle proteins were recognized. Antigen is efficiently transferred to bystander B cells by receptor-mediated uptake of released virions, resulting in recognition of target cells incubated with <1 virion/cell. T cell recognition does not require productive infection and occurs early after virus entry before latency is established. Glycoprotein-specific Th cells are cytolytic and inhibit proliferation of lymphoblastoid cell lines (LCL) and the outgrowth of LCL after infection of primary B cells with EBV. These results establish a novel role for glycoprotein-specific Th cells in the control of EBV infection and identify virion proteins as important immune targets. These findings have implications for the treatment of diseases associated with EBV and potentially other coated viruses infecting MHC class II–positive cells.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Virus-specific CD4⁺ T cells: ready for direct attack

Kevin N. Heller, Cagan Gurer, and Christian Münz
J. Exp. Med. 2006 203: 805-808. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Gurer, C., Strowig, T., Brilot, F., Pack, M., Trumpfheller, C., Arrey, F., Park, C. G., Steinman, R. M., Munz, C. (2008). Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood 112: 1231-1239 [Abstract] [Full Text]  
• Adhikary, D., Behrends, U., Feederle, R., Delecluse, H.-J., Mautner, J. (2008). Standardized and Highly Efficient Expansion of Epstein-Barr Virus-Specific CD4+ T Cells by Using Virus-Like Particles. J. Virol. 82: 3903-3911 [Abstract] [Full Text]  
• Brown, S. A., Hurwitz, J. L., Zirkel, A., Surman, S., Takimoto, T., Alymova, I., Coleclough, C., Portner, A., Doherty, P. C., Slobod, K. S. (2007). A Recombinant Sendai Virus Is Controlled by CD4+ Effector T Cells Responding to a Secreted Human Immunodeficiency Virus Type 1 Envelope Glycoprotein. J. Virol. 81: 12535-12542 [Abstract] [Full Text]  
• Tyznik, A. J., Bevan, M. J. (2007). The Surprising Kinetics of the T Cell Response to Live Antigenic Cells. J. Immunol. 179: 4988-4995 [Abstract] [Full Text]  
• Vescovini, R., Biasini, C., Fagnoni, F. F., Telera, A. R., Zanlari, L., Pedrazzoni, M., Bucci, L., Monti, D., Medici, M. C., Chezzi, C., Franceschi, C., Sansoni, P. (2007). Massive Load of Functional Effector CD4+ and CD8+ T Cells against Cytomegalovirus in Very Old Subjects. J. Immunol. 179: 4283-4291 [Abstract] [Full Text]  
• Onion, D., Crompton, L. J., Milligan, D. W., Moss, P. A. H., Lee, S. P., Mautner, V. (2007). The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein. J. Gen. Virol. 88: 2417-2425 [Abstract] [Full Text]  
• Delmas, S., Brousset, P., Clement, D., Le Roy, E., Davignon, J.-L. (2007). Anti-IE1 CD4+ T-cell clones kill peptide-pulsed, but not human cytomegalovirus-infected, target cells. J. Gen. Virol. 88: 2441-2449 [Abstract] [Full Text]  
• Wiertz, E. J., Devlin, R., Collins, H. L., Ressing, M. E. (2007). Herpesvirus Interference with Major Histocompatibility Complex Class II-Restricted T-Cell Activation. J. Virol. 81: 4389-4396 [Full Text]  
• Heemskerk, B., van Vreeswijk, T., Veltrop-Duits, L. A., Sombroek, C. C., Franken, K., Verhoosel, R. M., Hiemstra, P. S., van Leeuwen, D., Ressing, M. E., Toes, R. E. M., van Tol, M. J. D., Schilham, M. W. (2006). Adenovirus-Specific CD4+ T Cell Clones Recognizing Endogenous Antigen Inhibit Viral Replication In Vitro through Cognate Interaction. J. Immunol. 177: 8851-8859 [Abstract] [Full Text]  
• Milosevic, S., Behrends, U., Adhikary, D., Mautner, J. (2006). Identification of Major Histocompatibility Complex Class II-Restricted Antigens and Epitopes of the Epstein-Barr Virus by a Novel Bacterial Expression Cloning Approach.. J. Virol. 80: 10357-10364 [Abstract] [Full Text]  
• Feederle, R., Neuhierl, B., Baldwin, G., Bannert, H., Hub, B., Mautner, J., Behrends, U., Delecluse, H. J. (2006). Epstein-Barr Virus BNRF1 Protein Allows Efficient Transfer from the Endosomal Compartment to the Nucleus of Primary B Lymphocytes. J. Virol. 80: 9435-9443 [Abstract] [Full Text]  
• Taylor, G. S., Long, H. M., Haigh, T. A., Larsen, M., Brooks, J., Rickinson, A. B. (2006). A Role for Intercellular Antigen Transfer in the Recognition of EBV-Transformed B Cell Lines by EBV Nuclear Antigen-Specific CD4+ T Cells. J. Immunol. 177: 3746-3756 [Abstract] [Full Text]  
• Heller, K. N., Gurer, C., Munz, C. (2006). Virus-specific CD4+ T cells: ready for direct attack. J. Exp. Med. 203: 805-808 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS